Skip to main
CL

Colgate-Palmolive (CL) Stock Forecast & Price Target

Colgate-Palmolive (CL) Analyst Ratings

Based on 14 analyst ratings
Buy
Strong Buy 36%
Buy 36%
Hold 21%
Sell 7%
Strong Sell 0%

Bulls say

Colgate-Palmolive has demonstrated a strategic increase in advertising expenditure, rising from 11.6% of sales in 2021 to 13.5% in 2024, which likely indicates a commitment to strengthening brand visibility and market share. The company has also achieved growth in both price and volume from the second quarter of 2023 through the third quarter of 2024, showcasing its ability to drive revenue even in a competitive environment. Furthermore, with approximately 70% of its total business derived from international sales and strong positioning in emerging markets, Colgate-Palmolive is well-placed for sustained long-term growth.

Bears say

Colgate-Palmolive experienced a decline in gross margin of 75 basis points year-over-year in the second quarter of 2025, attributed to raw material inflation and tariffs, which signals potential pressure on profitability. Additionally, the dog food category, a significant segment of its business through Hill's, has shown a troubling downtrend with declining sales in U.S. retail channels, decreasing by 2.8% in 3Q25 year-to-date. Furthermore, Colgate-Palmolive reported negative volume growth of -0.3% in Q1 2025 and -0.9% in Q2 2025, despite managing positive price growth during the same periods, indicating weak demand or market challenges that could affect future growth.

Colgate-Palmolive (CL) has been analyzed by 14 analysts, with a consensus rating of Buy. 36% of analysts recommend a Strong Buy, 36% recommend Buy, 21% suggest Holding, 7% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Colgate-Palmolive and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Colgate-Palmolive (CL) Forecast

Analysts have given Colgate-Palmolive (CL) a Buy based on their latest research and market trends.

According to 14 analysts, Colgate-Palmolive (CL) has a Buy consensus rating as of Dec 27, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $89.29, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $89.29, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Colgate-Palmolive (CL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.